Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
RegeneCyte / StemCyte
NCT05682560: Human Umbilical Cord Blood (RegeneCyte) Infusion in Patients with Post-COVID Syndrome	Active, not recruiting	2	30	US	RegeneCyte, Placebo	StemCyte International, Ltd., StemCyte, Inc.	Long COVID, Post-COVID Syndrome, Post COVID-19 Condition	07/24	02/25